CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis-Reference-Cited by-同舟云学术

CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis

Published:2022-04 Issue:4 Volume:24 Page:337-350
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Gaedigk Andrea^ORCID,Boone Erin C.^ORCID,Scherer Steven E.,Lee Seung-been^ORCID,Numanagić Ibrahim^ORCID,Sahinalp Cenk^ORCID,Smith Joshua D.^ORCID,McGee Sean,Radhakrishnan Aparna^ORCID,Qin Xiang,Wang Wendy Y.^ORCID,Farrow Emily G.^ORCID,Gonzaludo Nina^ORCID,Halpern Aaron L.^ORCID,Nickerson Deborah A.,Miller Neil A.^ORCID,Pratt Victoria M.^ORCID,Kalman Lisa V.^ORCID

Funder

Indiana University School of Medicine

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference38 articles.

1. Physicochemical properties, biotransformation, and transport pathways of established and newly approved medications: a systematic review of the top 200 most prescribed drugs vs. the FDA-approved drugs between 2005 and 2016;Saravanakumar;Clin Pharmacokinet,2019

2. Pharmacogenomics of CYP2C9: functional and clinical considerations;Daly;J Pers Med,2017

3. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors;Hicks;Clin Pharmacol Ther,2015

4. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy;Moriyama;Clin Pharmacol Ther,2017

5. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities;Li;Drug Metab Dispos,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PharmVar GeneFocus: CYP4F2;Clinical Pharmacology & Therapeutics;2024-08-13

2. Benchmarking pharmacogenomics genotyping tools: Performance analysis on short‐read sequencing samples and depth‐dependent evaluation;Clinical and Translational Science;2024-08

3. Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers;Clinical Pharmacology & Therapeutics;2024-07-29

4. Considerations in Clinical Laboratory Development of Pharmacogenomic Testing;Advances in Molecular Pathology;2024-07

5. Education of Future Pharmacogenomics Laboratory Directors;Advances in Molecular Pathology;2024-07